Oct. 30, 2009 (Business Wire) -- GTx, Inc. (NASDAQ: GTXI) today announced that it will host a conference call and webcast on Monday, November 2, 2009 to provide an update regarding the New Drug Application for toremifene 80 mg to reduce fractures in men with prostate cancer on androgen deprivation therapy.
Conference Call
GTx will host the conference call and webcast on Monday, November 2, 2009 at 9:00 a.m. Eastern Time. To listen to the conference call, please dial:
| -- | | 888-396-2369 from the United States and Canada or |
| -- | | 617-847-8710 (International). |
| | | The access code for the call is 59484869. |
A playback of the call will be available beginning Monday at 11:00 a.m. Eastern Time through November 16, 2009, and may be accessed by dialing:
| -- | | 888-286-8010 from the United States and Canada or |
| -- | | 617-801-6888 (International) |
| | | The reservation number for the replay is 47774982. |
Additionally, you may access the live and subsequently archived webcast of the conference call from the Investor Relations section of the Company’s website at http://www.gtxinc.com.
